596 related articles for article (PubMed ID: 22192936)
1. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
Qian Y; Zhang HJ; Lv PC; Zhu HL
Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
5. Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation.
Li YW; Liu J; Liu N; Shi D; Zhou XT; Lv JG; Zhu J; Zheng CH; Zhou YJ
Bioorg Med Chem; 2011 Jun; 19(11):3579-84. PubMed ID: 21536450
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
[TBL] [Abstract][Full Text] [Related]
8. 3-substituted 2-phenylimidazo[2,1-b]benzothiazoles: synthesis, anticancer activity, and inhibition of tubulin polymerization.
Kamal A; Sultana F; Ramaiah MJ; Srikanth YV; Viswanath A; Kishor C; Sharma P; Pushpavalli SN; Addlagatta A; Pal-Bhadra M
ChemMedChem; 2012 Feb; 7(2):292-300. PubMed ID: 22241597
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
12. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.
Zhang H; Liu JJ; Sun J; Yang XH; Zhao TT; Lu X; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3212-8. PubMed ID: 22503741
[TBL] [Abstract][Full Text] [Related]
14. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Chiang YK; Lai MJ; Yeh JY; Wu SY; Chang JY; Liou JP; Hsieh HP
J Med Chem; 2008 Dec; 51(24):8163-7. PubMed ID: 19053773
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of aminostilbene-arylpropenones as tubulin polymerization inhibitors.
Kamal A; Kumar GB; Polepalli S; Shaik AB; Reddy VS; Reddy MK; Reddy ChR; Mahesh R; Kapure JS; Jain N
ChemMedChem; 2014 Nov; 9(11):2565-79. PubMed ID: 25146959
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.
Akselsen OW; Odlo K; Cheng JJ; Maccari G; Botta M; Hansen TV
Bioorg Med Chem; 2012 Jan; 20(1):234-42. PubMed ID: 22137934
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
